Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6051)
All Articles published online
|
Publishing Process of This Article
|
Nov 28, 2013 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol 2013; 19(44): 7846-7851 [PMID: 24307778 DOI: 10.3748/wjg.v19.i44.7846] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i44/7846.htm |
| Number | Citing Articles |
| 1 |
Marija Zeremski, Clewert Sylvester, Andrew H. Talal. Response to Commentary on Zeremski et al. (2016): Improvements in HCV-related Knowledge Among Substance Users on Opioid Agonist Therapy After an Educational Intervention. Journal of Addiction Medicine 2016; 10(5): 364 doi: 10.1097/ADM.0000000000000240
|
| 2 |
J. V. Lazarus, J. M. Pericàs, C. Picchio, J. Cernosa, M. Hoekstra, N. Luhmann, M. Maticic, P. Read, E. M. Robinson, J. F. Dillon. We know DAAs work, so now what? Simplifying models of care to enhance the hepatitis C cascade. Journal of Internal Medicine 2019; 286(5): 503 doi: 10.1111/joim.12972
|
| 3 |
Stephen A. Martin, Jordon Bosse, Amanda Wilson, Phyllis Losikoff, Lisa Chiodo. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care. Addiction Science & Clinical Practice 2018; 13(1) doi: 10.1186/s13722-018-0111-7
|
| 4 |
Andrew H. Talal, Yang Chen, Marija Zeremski, Roberto Zavala, Clewert Sylvester, Mary Kuhns, Lawrence S. Brown, Marianthi Markatou, Gavin A. Cloherty. Hepatitis C virus core antigen: A potential alternative to HCV RNA testing among persons with substance use disorders. Journal of Substance Abuse Treatment 2017; 78: 37 doi: 10.1016/j.jsat.2017.04.011
|
| 5 |
Clare Phillips, Jasmine Schulkind, Margaret O’Sullivan, Natalie Edelman, Helen E. Smith, Sumita Verma, Christina J. Jones. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT—An integrated community hepatitis C service. Journal of Viral Hepatitis 2020; 27(2): 176 doi: 10.1111/jvh.13214
|
| 6 |
Andrew H. Talal, Marianthi Markatou, Anran Liu, Ponni V. Perumalswami, Amreen M. Dinani, Jonathan N. Tobin, Lawrence S. Brown. Integrated Hepatitis C–Opioid Use Disorder Care Through Facilitated Telemedicine. JAMA 2024; doi: 10.1001/jama.2024.2452
|
| 7 |
Maria A. Corcorran, Judith I. Tsui, John D. Scott, Julia C. Dombrowski, Sara N. Glick. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington. Drug and Alcohol Dependence 2021; 220: 108525 doi: 10.1016/j.drugalcdep.2021.108525
|
| 8 |
Nyashadzaishe Mafirakureva, Jack Stone, Hannah Fraser, Yvonne Nzomukunda, Aron Maina, Angela W. Thiong'o, Kibango Walter Kizito, Esther W. K. Mucara, C. Inés González Diaz, Helgar Musyoki, Bernard Mundia, Peter Cherutich, Mercy Nyakowa, John Lizcano, Nok Chhun, Ann Kurth, Matthew J. Akiyama, Wanjiru Waruiru, Parinita Bhattacharjee, Charles Cleland, Dmytro Donchuk, Niklas Luhmann, Anne Loarec, David Maman, Josephine Walker, Peter Vickerman. An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis. Addiction 2022; 117(2): 411 doi: 10.1111/add.15630
|
| 9 |
Patrick Côté, Maykel F. Ghabrash, Julie Bruneau, Élise Roy, Simon Dubreucq, Emmanuel Fortier, Didier Jutras-Aswad. Association between mental health service utilisation and sharing of injection material among people who inject drugs in Montreal, Canada. Addictive Behaviors 2019; 96: 175 doi: 10.1016/j.addbeh.2019.05.010
|
| 10 |
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on Methadone. Clinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
|
| 11 |
Emily Hoff, Andrea Warden, Ruby Taylor, Ank E. Nijhawan. Hepatitis C Epidemiology in a Large Urban Jail: A Changing Demographic. Public Health Reports 2023; 138(2): 248 doi: 10.1177/00333549221076546
|
| 12 |
American Academy of Nursing: Hepatitis C testing in the birth cohort 1945-1965: Have you been tested?. Nursing Outlook 2014; 62(5): 371 doi: 10.1016/j.outlook.2014.07.006
|
| 13 |
Marisa Felsher, Karin E. Tobin, Mark Sulkowski, Carl Latkin, Oluwaseun Falade-Nwulia. HCV communication within ego-centric networks of men and women who inject drugs. Drug and Alcohol Dependence 2021; 229: 109157 doi: 10.1016/j.drugalcdep.2021.109157
|
| 14 |
Geert Robaeys, Rob Bielen. Hepatitis C: Care and Treatment. 2021; : 191 doi: 10.1007/978-3-030-67762-6_13
|
| 15 |
Marija Zeremski, Rositsa B. Dimova, Roberto Zavala, Steven Kritz, Melissa Lin, Bryce D. Smith, Jon E. Zibbell, Andrew H. Talal. Hepatitis C Virus–Related Knowledge and Willingness to Receive Treatment Among Patients on Methadone Maintenance. Journal of Addiction Medicine 2014; 8(4): 249 doi: 10.1097/ADM.0000000000000041
|
| 16 |
Stevan A. Gonzalez, Daniel S. Fierer, Andrew H. Talal. Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection. Addictive Disorders & Their Treatment 2017; 16(2): S1 doi: 10.1097/ADT.0000000000000104
|
| 17 |
Annie Pedlar, Prabjot (Jodie) Sandhu. Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities. Journal of the American Association of Nurse Practitioners 2020; 32(8): 563 doi: 10.1097/JXX.0000000000000269
|
| 18 |
Alain H. Litwin, Martine Drolet, Chizoba Nwankwo, Martha Torrens, Andrej Kastelic, Stephan Walcher, Lorenzo Somaini, Emily Mulvihill, Jochen Ertl, Jason Grebely. Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study. Journal of Viral Hepatitis 2019; 26(9): 1094 doi: 10.1111/jvh.13119
|
| 19 |
Phillip J. Summers, Julia L. Hellman, Madison R. MacLean, Vaughan W. Rees, Michael S. Wilkes. Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis. Drug and Alcohol Dependence 2018; 190: 200 doi: 10.1016/j.drugalcdep.2018.06.010
|
| 20 |
Carolina Barbosa, Hannah Fraser, Thomas J. Hoerger, Alyssa Leib, Jennifer R. Havens, April Young, Alex Kral, Kimberly Page, Jennifer Evans, Jon Zibbell, Susan Hariri, Claudia Vellozzi, Lina Nerlander, John W. Ward, Peter Vickerman. Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs. Addiction 2019; 114(12): 2267 doi: 10.1111/add.14731
|
| 21 |
Benjamin P. Linas, Shayla Nolen. A Guide to the Economics of Hepatitis C Virus Cure in 2017. Infectious Disease Clinics of North America 2018; 32(2): 447 doi: 10.1016/j.idc.2018.02.013
|
| 22 |
Karli R. Hochstatter, Lauren J. Stockman, Ryan Holzmacher, James Greer, David W. Seal, Quinton A. Taylor, Emma K. Gill, Ryan P. Westergaard. The continuum of hepatitis C care for criminal justice involved adults in the DAA era: a retrospective cohort study demonstrating limited treatment uptake and inconsistent linkage to community-based care. Health & Justice 2017; 5(1) doi: 10.1186/s40352-017-0055-0
|
| 23 |
Jaimie P. Meyer, Yavar Moghimi, Ruthanne Marcus, Joseph K. Lim, Alain H. Litwin, Frederick L. Altice. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic Hepatitis C care continuum. International Journal of Drug Policy 2015; 26(10): 922 doi: 10.1016/j.drugpo.2015.05.002
|
| 24 |
Yeba H. Adje, Kristina M. Brooks, Jose R. Castillo-Mancilla, David L. Wyles, Peter L. Anderson, Jennifer J. Kiser. The use of technology-based adherence monitoring in the treatment of hepatitis C virus. Therapeutic Advances in Infectious Disease 2022; 9: 204993612210956 doi: 10.1177/20499361221095664
|
| 25 |
Rozalyn Milne, Morgan Price, Bruce Wallace, Anne Drost, Irene Haigh-Gidora, Frank A. Nezil, Chris Fraser. From principles to practice: Description of a novel equity-based HCV primary care treatment model for PWID. International Journal of Drug Policy 2015; 26(10): 1020 doi: 10.1016/j.drugpo.2015.07.009
|
| 26 |
Sharon J. Hutchinson, John F. Dillon, Ray Fox, Scott A. McDonald, Hamish A. Innes, Amanda Weir, Allan McLeod, Esther J. Aspinall, Norah E. Palmateer, Avril Taylor, Alison Munro, Heather Valerio, Gareth Brown, David J. Goldberg. Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience. International Journal of Drug Policy 2015; 26(11): 1041 doi: 10.1016/j.drugpo.2015.05.019
|
| 27 |
O. Falade‐Nwulia, S. H. Mehta, J. Lasola, C. Latkin, A. Niculescu, C. O'Connor, P. Chaulk, K. Ghanem, K. R. Page, M. S. Sulkowski, D. L. Thomas. Public health clinic‐based hepatitis C testing and linkage to care in baltimore. Journal of Viral Hepatitis 2016; 23(5): 366 doi: 10.1111/jvh.12507
|
| 28 |
Jessica M. Downes, Anthony Donovan, Carrie McAdam-Marx. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center. Journal of the American Pharmacists Association 2022; 62(5): 1596 doi: 10.1016/j.japh.2022.04.014
|
| 29 |
Selina Barbati, Johannes Strasser, Samuel S. Allemann, Isabelle Arnet. Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study. Health Science Reports 2024; 7(1) doi: 10.1002/hsr2.1814
|
| 30 |
Maria Stepanova, Alexander Thompson, Joseph Doyle, Issah Younossi, Leyla de Avila, Zobair M Younossi. Hepatitis C Virus–Infected Patients Receiving Opioid Substitution Therapy Experience Improvement in Patient-Reported Outcomes Following Treatment With Interferon-Free Regimens. The Journal of Infectious Diseases 2018; 217(7): 1033 doi: 10.1093/infdis/jix681
|
| 31 |
Evan B. Cunningham, Alice Wheeler, Behzad Hajarizadeh, Clare E. French, Rachel Roche, Alison D. Marshall, Guillaume Fontaine, Anna Conway, Sahar Bajis, Braulio M. Valencia, Justin Presseau, John W. Ward, Louisa Degenhardt, Gregory J. Dore, Matthew Hickman, Peter Vickerman, Jason Grebely. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. International Journal of Drug Policy 2023; 111: 103917 doi: 10.1016/j.drugpo.2022.103917
|
| 32 |
Suzanne Barror, Gordana Avramovic, Cristiana Oprea, Julian Surey, Alistair Story, Juan Macías, Walter Cullen, Des Crowley, Aidan Horan, Anna Marie Naughton, Maria Iglesias, Irina Ianache, Stefan Lazar, Ionut Popa, Tina McHugh, Dee Menezes, Willard Tinago, John S Lambert. HepCare Europe: a service innovation project. HepCheck: enhancing HCV identification and linkage to care for vulnerable populations through intensified outreach screening. A prospective multisite feasibility study. Journal of Antimicrobial Chemotherapy 2019; 74(Supplement_5): v39 doi: 10.1093/jac/dkz455
|
| 33 |
Kiva A. Fisher, Stephen Phillippi, William T. Robinson. Resilience, Distress, and Dependence Influence Injection Related Risk among People Who Inject Drugs. International Journal of Mental Health and Addiction 2020; 18(3): 587 doi: 10.1007/s11469-018-9955-z
|
| 34 |
Andrew H. Talal, Urmo Jaanimägi, Kathleen Davis, Jordan Bailey, Barbara M. Bauer, Arpan Dharia, Saliyah George, Anthony McLeod, Karen Morton, Ann Nugent, Marija Zeremski, Amreen Dinani, Don C. Des Jarlais, Ponni V. Perumalswami, Jonathan N. Tobin, Suzanne S. Dickerson. Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers. Journal of Substance Abuse Treatment 2021; 127: 108421 doi: 10.1016/j.jsat.2021.108421
|
| 35 |
Paula Tookey, Kate Mason, Jennifer Broad, Marty Behm, Lise Bondy, Jeff Powis. From client to co-worker: a case study of the transition to peer work within a multi-disciplinary hepatitis c treatment team in Toronto, Canada. Harm Reduction Journal 2018; 15(1) doi: 10.1186/s12954-018-0245-7
|
| 36 |
Issifou Yaya, Perrine Roux, Fabienne Marcellin, Linda Wittkop, Laure Esterle, Bruno Spire, Stéphanie Dominguez, Boni Armand Elegbe, Lionel Piroth, Philippe Sogni, Dominique Salmon-Ceron, Maria Patrizia Carrieri, Yury E. Khudyakov. Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infected patients. PLOS ONE 2018; 13(7): e0199874 doi: 10.1371/journal.pone.0199874
|
| 37 |
Gordana Avramovic, Cristiana Oprea, Julian Surey, Alistair Story, Juan Macías, Walter Cullen, Maria Iglesias, Tina Mc Hugh, Des Crowley, Anna Marie Naughton, Aidan Horan, Irina Ianache, Stefan Lazar, Ionut Popa, Dee Menezes, John S Lambert. HepCare Europe—A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA. International Journal of Infectious Diseases 2020; 91: 246 doi: 10.1016/j.ijid.2019.11.027
|
| 38 |
Karli R Hochstatter, David H Gustafson Sr, Gina Landucci, Klaren Pe-Romashko, Adam Maus, Dhavan V Shah, Quinton A Taylor, Emma K Gill, Rebecca Miller, Sarah Krechel, Ryan P Westergaard. A Mobile Health Intervention to Improve Hepatitis C Outcomes Among People With Opioid Use Disorder: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2019; 8(8): e12620 doi: 10.2196/12620
|
| 39 |
Gregory J. Moran, Surya Chitra, Paul C. McGovern. Efficacy and Safety of Omadacycline Versus Linezolid in Acute Bacterial Skin and Skin Structure Infections in Persons Who Inject Drugs. Infectious Diseases and Therapy 2022; 11(1): 517 doi: 10.1007/s40121-021-00587-4
|
| 40 |
Phyllis Losikoff, Jordon D. Bosse, Stephen A. Martin, Amanda Wilson, Lisa M. Chiodo. Integrated hepatitis C treatment is associated with improved retention and success in outpatient treatment for opioid use disorder at a private clinic. Frontiers in Psychiatry 2022; 13 doi: 10.3389/fpsyt.2022.932306
|
| 41 |
Stacey B Trooskin, Gregory Dore, Jay Kostman. We Must Do Better: Addressing HCV Treatment Barriers in Persons Who Inject Drugs in the United States. The Journal of Infectious Diseases 2020; 222(Supplement_9): S773 doi: 10.1093/infdis/jiaa574
|
| 42 |
Natalie A. Blackburn, Rajiv C. Patel, Jon E. Zibbell. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012–2014. Public Health Reports 2016; 131(2_suppl): 91 doi: 10.1177/00333549161310S214
|
| 43 |
Basmattee Boodram, Anna L. Hotton, Louis Shekhtman, Alexander Gutfraind, Harel Dahari. High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members. Journal of Urban Health 2018; 95(1): 71 doi: 10.1007/s11524-017-0185-7
|
| 44 |
Oluwaseun Falade‐Nwulia, Rachel E. Gicquelais, Jacquie Astemborski, Sean D. McCormick, Greg Kirk, Mark Sulkowski, David L. Thomas, Shruti H. Mehta. Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era. Liver International 2020; 40(10): 2407 doi: 10.1111/liv.14634
|
| 45 |
Omar T. Sims, Quentin R. Maynard, Pam A. Melton. Behavioral Interventions to Reduce Alcohol Use Among Patients with Hepatitis C: A Systematic Review. Social Work in Public Health 2016; 31(6): 565 doi: 10.1080/19371918.2016.1160346
|
| 46 |
Susan L Stewart, Sandy L Kwong, Christopher L Bowlus, Tung T Nguyen, Annette E Maxwell, Roshan Bastani, Eric W Chak, Moon S Chen Jr. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. World Journal of Gastroenterology 2016; 22(38): 8584-8595 doi: 10.3748/wjg.v22.i38.8584
|
| 47 |
Imran Shahid, Waleed Hassan AlMalki, Sajida Hassan, Muhammad Hassan Hafeez. Real-world challenges for hepatitis C virus medications: a critical overview. Critical Reviews in Microbiology 2018; 44(2): 143 doi: 10.1080/1040841X.2017.1329277
|
| 48 |
Anna Versfeld, Angela McBride, Andrew Scheibe, C. Wendy Spearman. Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities. Harm Reduction Journal 2020; 17(1) doi: 10.1186/s12954-020-00382-3
|
| 49 |
KariLynn Dowling-McClay, Stephanie M. Mathis, Nicholas Hagemeier. Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake. Exploratory Research in Clinical and Social Pharmacy 2021; 4: 100088 doi: 10.1016/j.rcsop.2021.100088
|
| 50 |
Zoë Dodd, Claire Ann Banga, Kate Mason, Christopher Meaney, Molyn Leszcz, Sanjeev Sockalingam. Engagement in Group Psychotherapy Among Marginalized Individuals With Hepatitis C. International Journal of Group Psychotherapy 2016; 66(3): 338 doi: 10.1080/00207284.2016.1149410
|
| 51 |
Soraia Mafra Machado, Cesar de Almeida Neto, João Renato Rebello Pinho, Fernanda de Mello Malta, Ligia Capuani, Aléia Faustina Campos, Fatima Regina Marques Abreu, Ana Catharina de Seixas Santos Nastri, Rúbia Anita Ferraz Santana, Ester Cerdeira Sabino, Maria Cássia Mendes-Correa. Hepatitis C among blood donors: cascade of care and predictors of loss to follow-up. Revista de Saúde Pública 2017; 51(0) doi: 10.1590/s1518-8787.2017051006468
|
| 52 |
Marija Zeremski, Anthony Martinez. Liver Disease and Fibrosis Assessment in Substance Use–Related Disorders. Clinical Pharmacology in Drug Development 2017; 6(2): 164 doi: 10.1002/cpdd.312
|
| 53 |
Leith Morris, Linda Selvey, Owain Williams, Charles Gilks, Andrew Smirnov. Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs. Substance Use & Misuse 2021; 56(2): 175 doi: 10.1080/10826084.2020.1846198
|
| 54 |
Jason Grebely, Martine Drolet, Chizoba Nwankwo, Martha Torrens, Andrej Kastelic, Stephan Walcher, Lorenzo Somaini, Emily Mulvihill, Jochen Ertl, Ryan Liebert, Alain H. Litwin. Perceptions and self-reported competency related to testing, management and treatment of hepatitis C virus infection among physicians prescribing opioid agonist treatment: The C-SCOPE study. International Journal of Drug Policy 2019; 63: 29 doi: 10.1016/j.drugpo.2018.10.012
|
| 55 |
Delia Motavalli, Jessica L. Taylor, Ellen Childs, Pablo K. Valente, Peter Salhaney, Jennifer Olson, Dea L. Biancarelli, Alberto Edeza, Joel J. Earlywine, Brandon D. L. Marshall, Mari-Lynn Drainoni, Matthew J. Mimiaga, Katie B. Biello, Angela R. Bazzi. “Health Is on the Back Burner:” Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs. Journal of General Internal Medicine 2021; 36(1): 129 doi: 10.1007/s11606-020-06201-6
|
| 56 |
Sercan KARABULUT. Effects of Recent IV Drug Use and Severity of Psychiatric Symptoms to Antiviral Treatment in People Who Inject Drugs. Bağımlılık Dergisi 2023; 24(1): 12 doi: 10.51982/bagimli.1105469
|
| 57 |
Zakaria Belrhiti, Fatima Zohra Serghini. Perceived barriers to access to hepatitis C for people who inject drugs in Morocco: A qualitative explorative study. Drug Science, Policy and Law 2023; 9 doi: 10.1177/20503245231199163
|
| 58 |
Rui Tato Marinho, António Costa, Teodomiro Pires, Helena Raposo, Carlos Vasconcelos, Cristina Polónia, Joaquim Borges, Mariana Soares, Graça Vilar, Ana Maria Nogueira. A multidimensional education program at substance dependence treatment centers improves patient knowledge and hepatitis C care. BMC Infectious Diseases 2016; 16(1) doi: 10.1186/s12879-016-1883-6
|
| 59 |
M. C. Thurnheer, T. R. Schulz, T. Nguyen, J. MacLachlan, J. Sasadeusz. Regional challenges: evaluation of a hepatitis outreach programme using transient elastography (FibroScan) in Victoria. Internal Medicine Journal 2016; 46(3): 273 doi: 10.1111/imj.12963
|
| 60 |
Amy B. Jessop, Sarah Bauerle Bass, Jesse Brajuha, Mohammed Alhajji, Monika Burke, Muhamed Tahar Gashat, Carine Wellington, Nicole Ventriglia, Jennie Coleman, Paul D'Avanzo. “Take Charge, Get Cured”: Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy. Journal of Substance Abuse Treatment 2020; 109: 23 doi: 10.1016/j.jsat.2019.11.001
|
| 61 |
Eric G Hilgenfeldt, Alex Schlachterman, Roberto J Firpi. Hepatitis C: Treatment of difficult to treat patients. World Journal of Hepatology 2015; 7(15): 1953-1963 doi: 10.4254/wjh.v7.i15.1953
|
| 62 |
Avni Mittal, Karen C. Kosinski, Thomas J. Stopka. HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016. Harm Reduction Journal 2019; 16(1) doi: 10.1186/s12954-019-0314-6
|
| 63 |
Oluwaseun Falade‐Nwulia, Kathleen M. Ward, Sean McCormick, Shruti H. Mehta, Stephanie R. Pitts, Stephanie Katz, Geetanjali Chander, David L. Thomas, Mark Sulkowski, Carl A. Latkin. Network‐based recruitment of people who inject drugs for hepatitis C testing and linkage to care. Journal of Viral Hepatitis 2020; 27(7): 663 doi: 10.1111/jvh.13274
|
| 64 |
Angelique Myles. The Role of Physicians’ Attitudes and the Provision of Hepatitis C Virus Treatment to People Who Inject Drugs. Open Medicine Journal 2016; 3(1): 104 doi: 10.2174/1874220301603010104
|
| 65 |
Nik Howes, Sam Lattimore, William Lucien Irving, Brian James Thomson. Clinical Care Pathways for Patients With Hepatitis C: Reducing Critical Barriers to Effective Treatment. Open Forum Infectious Diseases 2016; 3(1) doi: 10.1093/ofid/ofv218
|
| 66 |
Stella A. Safo, Abigail Batchelder, Deena Peyser, Alain H. Litwin. The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perception. Harm Reduction Journal 2015; 12(1) doi: 10.1186/s12954-015-0054-1
|
| 67 |
Yasmin A Saeed, Kate Mason, Nicholas Mitsakakis, Jordan J Feld, Karen E Bremner, Arcturus Phoon, Alice Fried, Josephine F Wong, Jeff Powis, Murray D Krahn, William WL Wong. Disparities in health utilities among hepatitis C patients receiving care in different settings. Canadian Liver Journal 2023; 6(1): 24 doi: 10.3138/canlivj-2022-0009
|
| 68 |
Nayana George, Sherrie M. Harrell, Kimberly D. Rhodes, Andres Duarte-Rojo. Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy. Annals of Hepatology 2018; 17(1): 76 doi: 10.5604/01.3001.0010.7537
|
| 69 |
Jean-Michel Delile, Victor de Ledinghen, Marie Jauffret-Roustide, Perrine Roux, Brigitte Reiller, Juliette Foucher, Daniel Dhumeaux. Hepatitis C virus prevention and care for drug injectors: the French approach. Hepatology, Medicine and Policy 2018; 3(1) doi: 10.1186/s41124-018-0033-8
|
| 70 |
Maria A Corcorran, Jenell Stewart, Kristine Lan, Ayushi Gupta, Sara N Glick, Chetan Seshadri, Kevin J Koomalsingh, Edward F Gibbons, Robert D Harrington, Shireesha Dhanireddy, H Nina Kim. Correlates of 90-Day Mortality Among People Who Do and Do Not Inject Drugs With Infective Endocarditis in Seattle, Washington. Open Forum Infectious Diseases 2022; 9(5) doi: 10.1093/ofid/ofac150
|